Literature DB >> 6245237

Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.

N Rosenberg, O N Witte.   

Abstract

Abelson murine leukemia virus (A-MuLV) is a replication-defective virus that transforms both fibroblasts and hematopoietic cells in vitro. The virus encodes a 120,000-molecular-weight protein (P120) that is composed of Moloney murine leukemia virus-derived gag gene sequences and A-MuLV--specific sequences. This protein is the only A-MuLV--encoded protein that has been detected, and thus P120 is a candidate for the transforming protein of A-MuLV. We now report isolation and characterization of three new A-MuLV isolates that do not synthesize P120 but do produce analogous proteins of larger (160,000 molecular weight) and smaller (100,000 and 90,000 molecular weight) size. All of these A-MuLV isolates transform fibroblasts and lymphoid cells in vitro. Because the different A-MuLV proteins vary in the A-MuLV--specific region of the molecule, these variants may set a maximum limit on the size of the A-MuLV transforming protein.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245237      PMCID: PMC288551     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Authors:  C D Scher; R Siegler
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

3.  In vitro transformation of lymphoid cells by Abelson murine leukemia virus.

Authors:  N Rosenberg; D Baltimore; C D Scher
Journal:  Proc Natl Acad Sci U S A       Date:  1975-05       Impact factor: 11.205

4.  Rapid viral induction of plasmacytomas in pristane-primed BALB-c mice.

Authors:  M Potter; M D Sklar; W P Rowe
Journal:  Science       Date:  1973-11-09       Impact factor: 47.728

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Rapid cell culture assay technic for murine leukaemia viruses.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Nature       Date:  1971-02-19       Impact factor: 49.962

7.  Influence of prednisolone on Moloney leukemogenic virus in BALB-c mice.

Authors:  H T Abelson; L S Rabstein
Journal:  Cancer Res       Date:  1970-08       Impact factor: 12.701

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

10.  Measurement of the sequence complexity of cloned Moloney murine leukemia virus 60 to 70S RNA: evidence for a haploid genome.

Authors:  H Fan; M Paskind
Journal:  J Virol       Date:  1974-09       Impact factor: 5.103

View more
  41 in total

1.  Functional characterization of B lymphocytes generated in vitro from embryonic stem cells.

Authors:  S K Cho; T D Webber; J R Carlyle; T Nakano; S M Lewis; J C Zúñiga-Pflücker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.

Authors:  R W Rees-Jones; S P Goff
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Gag influences transformation by Abelson murine leukemia virus and suppresses nuclear localization of the v-Abl protein.

Authors:  Chae-Ryun Yi; Naomi Rosenberg
Journal:  J Virol       Date:  2007-06-27       Impact factor: 5.103

4.  Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.

Authors:  K Parmar; R C Huebner; N Rosenberg
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

5.  The carboxyl terminus of v-Abl protein can augment SH2 domain function.

Authors:  D Warren; A J Heilpern; K Berg; N Rosenberg
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.

Authors:  S M Watanabe; N E Rosenberg; O N Witte
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

7.  Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.

Authors:  Erica Marchlik; Richard Kalman; Naomi Rosenberg
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Abelson murine leukemia virus: structural requirements for transforming gene function.

Authors:  A Srinivasan; C Y Dunn; Y Yuasa; S G Devare; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

9.  Transformation-associated proteins in murine B-cell lymphomas that are distinct from Abelson virus gene products.

Authors:  E Pillemer; C Whitlock; I L Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.

Authors:  O N Witte; S Goff; N Rosenberg; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.